Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Exelixis Inc’s current trading price is -9.87% away from its 52-week high, while its distance from the 52-week low is 101.79%. The stock’s price range during this period has varied between $21.82 and $48.85. The company, active in the Healthcare sector, saw a trading volume of around 5.73 million for the day, considerably higher average daily volume of 3.04 million observed over the last three months.
The market performance of Exelixis Inc has been somewhat stable.
How Financial Performance Impacts Market Capitalization
Exelixis Inc (EXEL) has experienced a quarterly rise of 19.13% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 12.01B and boasts a workforce of 1147 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
How EXEL’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for EXEL stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.09.
EXEL Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a gain of 104.22%.However, over the last six months, we can see a weaker performance of 26.92%. Over the last 30 days, the price of EXEL has fallen by 0.71%. And in the last five days, it has surged by 5.87%.
